Low Dose Magnesium Sulphate

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 25, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions
Mean Arterial Pressure
Interventions
DRUG

Patients will receive propranolol 1-2 mg.

Patients will receive propranolol 1-2 mg. prepared in a 10 ml syringe (100 ug/ml).

DRUG

Patient receives magnesium sulphate

Magnesium sulphate 10%: 1g ampoule (10ml), will be prepared in a syringe pump to be given at a rate of 40 ml/hr . Another syringe of 10 ml 0.9% sodium chloride will be prepared to be given in group (P).

Trial Locations (1)

69711

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER